HLF News 67.48 07/29/2014 05:17:52 Herbalife Ltd (HLF)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Herbalife Ltd (HLF) 67.48 $HLF

Herbalife 2Q profit falls 17 percent
AP - Mon Jul 28, 5:03PM CDT
GEORGE TOWN, Cayman Islands (AP) — Herbalife Ltd. (HLF) on Monday reported profit that decreased by 17 percent in its second quarter, and missed analysts' expectations.

After Yesterday's Rally of 2.15% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon Jul 28, 3:56PM CDT
Herbalife (NYSE:HLF) traded in a range yesterday that spanned from a low of $66.23 to a high of $69.69. Yesterday, the shares gained 2.1%, which took the trading range above the 3-day high of $67.15 on volume of 5.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Look for Shares of Herbalife to Potentially Pullback after Yesterday's 2.15% Rise
Comtex SmarTrend(R) - Mon Jul 28, 3:55PM CDT
Herbalife (NYSE:HLF) traded in a range yesterday that spanned from a low of $66.23 to a high of $69.69. Yesterday, the shares gained 2.1%, which took the trading range above the 3-day high of $67.15 on volume of 5.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Why Herbalife (HLF) Stock Is Plunging in After-Hours Trading Today
at The Street - Mon Jul 28, 3:40PM CDT
Herbalife (HLF) plunged in after-hours trading on Monday after the nutrition and weight management company reported second-quarter earnings that came up short of analysts' expectations.

Herbalife Ltd. Announces Second Quarter 2014 Results and Raises 2014 Earnings Guidance
Business Wire - Mon Jul 28, 3:32PM CDT
--Adjusted(1) EPS of $1.55 increased 10 percent compared to the prior year. Reported EPS of $1.31 primarily reflects the impact of the non-cash costs associated with the convert and other items.

What to Expect When Herbalife (HLF) Reports Second-Quarter Earnings Today
at The Street - Mon Jul 28, 1:59PM CDT
Herbalife (HLF) reports second-quarter earnings after the closing bell on Tuesday, and here's what analysts are expecting from the nutrition and weight management company.

Why Jim Cramer Would Buy Twitter (TWTR) Stock If It Drops After Earnings Report
at The Street - Mon Jul 28, 12:59PM CDT
TheStreet's Jim Cramer explains why he considers Twitter a "battleground stock."

Is Herbalife (HLF) Poised to Beat Earnings Estimates? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jul 28, 8:00AM CDT
Herbalife Ltd (HLF) is set to report second quarter 2014 results today after the market closes. Last quarter, it posted an impressive earnings surprise of 16.28%. Let's see how things are shaping up for this announcement.

Herbalife partners with Asian Pacific American Institute for Congressional Studies to support a Congressional Fellow
M2 - Mon Jul 28, 4:20AM CDT
Global nutrition company Herbalife (NYSE: HLF) announced on Friday a partnership with the Asian Pacific American Institute for Congressional Studies (APAICS) to support a congressional fellowship in Washington DC.

Herbalife names Alan Hoffman as EVP of Global Corporate Affairs
M2 - Mon Jul 28, 3:17AM CDT
Global nutrition company Herbalife Ltd (NYSE: HLF) announced on Friday the appointment of Alan L Hoffman to the newly created role of executive vice president of Global Corporate Affairs, effective 25 August 2014.

5 Stocks to Watch This Week
Rick Munarriz, The Motley Fool - Motley Fool - Sat Jul 26, 9:00AM CDT
There's never a dull week on Wall Street. Let's go over some of the news that will shape the week to come. Monday Herbalife   has been busy this past week. The stock took a hit when Bill Ackman promised to expose the distribution of nutritional...

Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan
at The Street - Fri Jul 25, 6:51PM CDT
As global tensions ratchet up the worry, investors need to raise cash and stay largely on the sidelines, Cramer advises.

Will Herbalife Exceed Earnings Expectations for the 22nd Consecutive Quarter?
Joseph Solitro, The Motley Fool - Motley Fool - Fri Jul 25, 9:00AM CDT
Herbalife , the global nutrition company, has watched its stock widely underperform the overall market in 2014. However, this has not been the result of a weak financial performance; in fact, the company has exceeded expectations in both of its...

Herbalife Appoints Alan Hoffman Executive Vice President of Global Corporate Affairs
Business Wire - Fri Jul 25, 7:27AM CDT
Herbalife Ltd. (NYSE: HLF) today announced that it has appointed Alan L. Hoffman to the newly established role of Executive Vice President of Global Corporate Affairs reporting to Michael O. Johnson, Herbalife's chairman and CEO. Hoffman will lead public policy, corporate communications, government affairs, community relations and philanthropy, effective August 25, 2014.

Herbalife Announces Partnership with Asian Pacific American Institute for Congressional Studies to Support a Congressional Fellow
Business Wire - Fri Jul 25, 7:01AM CDT
Today, Herbalife (NYSE: HLF), a leading global nutrition company, announced that the company is partnering with the Asian Pacific American Institute for Congressional Studies (APAICS) to support a congressional fellowship in Washington, D.C. As part of the program, Herbalife will sponsor Alyssa Wang, a recent graduate of the University of Florida who will spend nine months in Washington D.C. getting invaluable experience working in the U.S. Congress.

What Gordon Gekko Could Teach Bill Ackman
Chris Hill and Tim Hanson, The Motley Fool - Motley Fool - Thu Jul 24, 7:48PM CDT
On Thursday's Market Foolery , host Chris Hill and Motley Fool Funds analyst Tim Hanson shake out the emotional conviction of Ackman's attack on Herbalife . Bill Ackman is clearly against Herbalife. In December, Ackman announced he staked $1...

Has Bill Ackman Delivered the Deathblow to Herbalife?
Sam Mattera, The Motley Fool - Motley Fool - Thu Jul 24, 4:34PM CDT
"Maybe I didn't do a good job," Bill Ackman said, toward the end of his more than three-hour-long Herbalife presentation on Tuesday. With Herbalife shares surging more than 25% during the session, even as the founder of hedge fund Pershing Square...

NTRR Explores Developing All-Natural Alternative to Adderall
Business Wire - Thu Jul 24, 6:26AM CDT
In its mission to deliver all-natural, cutting-edge wellness solutions, Neutra Corp. (OTCBB: NTRR) is exploring the development of an herbal supplement alternative to the drug Adderall.

The Curious Case of William Ackman
at The Street - Wed Jul 23, 4:08PM CDT
Sometimes a smoking gun is loaded with blanks

Stock Market Today: Record Intraday Moves for S&P 500 on Apple, Pepsi Earnings
at The Street - Wed Jul 23, 3:19PM CDT
U.S. stocks close mixed Wednesday as investors digest earnings from some of the biggest market players including Apple, PepsiCo and Microsoft.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 146

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Fibocom Unveils U6G Solutions Advancing Global 5G Tech

Updated Category News Views 60

Breaking Barriers with U6G-Capable Technology Sneaking into the industry's spotlight at MWC Doha 2026, Fibocom flaunts a robust lineup of next-gen 5G solutions. It's as if they're shuffling every card they’ve got to win over the broadband world. With breakthroughs like the FG390, FG370, and FG670 modules, alongside PCBA-level innovations, Fibocom is not just throwing...

Continue Reading
Strathcona and Greenfire Set Sights on Major Merger

Updated Category News Views 68

Strathcona's Bold Move for Greenfire: A Game Changer? Just this week, Strathcona Resources Ltd. decided to make a big splash in the oil sands space by proposing to acquire Greenfire Resources Ltd. This isn’t your run-of-the-mill grab—it's a strategic tango expected to shift billions and reshape what we know about Canada’s oil sands territory. Unpicking the Deal...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 272

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 354

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 414

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 646

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Cars.com Inducement Awards: New CPO Earns Stock Boost

Updated Category News Views 22

Revving Up With Incentives: A Strategic Move by Cars.com Ever seen a stock maneuver that feels more like a chess play than a plain deal? On November 5, 2026, Cars.com (NYSE: CARS) fired up quite a strategic engine. They handed out a heap of restricted stock units—373,345 to be precise—to Mausam Bhatt, freshly minted as their Chief Product Officer. This isn't just your...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 586

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading

Top 5 Most Recently Viewed Articles

Spring Health Launches Initiative for Mental Health Relief

Updated Category News Views 472

Spring Health's Commitment to Mental Health Support In response to the recent devastation from the wildfires, Spring Health has announced a significant initiative aimed at providing mental health resources to those in distress. The company has committed $500,000 to launch a new Wildfire Mental Health Support Program aimed at individuals and families impacted by these...

Continue Reading
Serina Therapeutics Showcases Innovations at Global Conference

Updated Category News Views 263

Serina Therapeutics Takes the Stage at Major Investment Event Serina Therapeutics, Inc., also known as Serina (NYSE American: SER), is set to make an impactful presentation at the H.C. Wainwright 27th Annual Global Investment Conference. This prestigious event unfolds in New York City, where Steve Ledger, the Chief Executive Officer of Serina, will take the spotlight at...

Continue Reading
Patrick Industries Faces Scrutiny Amid Merger Plans

Updated Category News Views 48

Cracks in the Merger Deal? Nobody likes it when a seemingly routine merger suddenly faces the magnifying glass of a class action attorney. But that's where we are with Patrick Industries (NASDAQ: PATK), folks. Juan Monteverde, the big hitter from Monteverde & Associates, is eyeing this one closely. This New York-based firm, perched in the legendary Empire State Building...

Continue Reading
Revolutionary Arab Human Pangenome: Advancing Genomic Equity

Updated Category News Views 124

Groundbreaking Achievement in Genomics PacBio, a renowned leader in sequencing technology, has made a substantial contribution to global genomics with the announcement of the first Arab human pangenome. This historic achievement is powered by their innovative HiFi long-read sequencing technology, showcasing the potential of genomic science to progress health equality...

Continue Reading
RCI Hospitality Secures Significant Legal Representation Ahead of Deadline

Updated Category News Views 226

Introduction to RCI Hospitality Holdings, Inc. RCI Hospitality Holdings, Inc. (NASDAQ: RICK) is known for its diverse portfolio in the hospitality sector. With establishments across the country, RCI focuses on providing entertainment and dining experiences through various brands. As an investor in RCI Hospitality, it’s essential to stay informed about recent legal...

Continue Reading